Ebba Gløersen Müller

Ebba Gløersen Müller

Auto-generated profile, based on publicly available information

Ebba Gløersen Müller

Division of Radiology and Nuclear Medicine, Department of Nuclear Medicine, Oslo University Hospital, Oslo, Norway

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EMEbba Gløersen Müller
Ebba Gløersen Müller
TETrine Holt Edwin
Trine Holt Edwin
CSCaroline Stokke
Caroline Stokke
SNSigrid Stensby Navelsaker
Sigrid Stensby Navelsaker
ABAlmira Babovic
Almira Babovic
MRMona Elisabeth Revheim
Mona Elisabeth Revheim
Alzheimer’s disease (AD) remains a clinical diagnosis but biomarkers from cerebrospinal fluid (CSF) and more lately amyloid imaging with positron emission tomography (PET), are important to support a diagnosis of AD. To compare amyloid-β (Aβ) PET imaging with biomarkers in CSF and evaluate the prediction of Aβ PET on diagnosis in a memory clinic setting. We included 64 patients who had lumbar puncture and Aβ PET with 18F-Flutemetamol performed within 190 days. PET was binary classified (Flut+ or Flut-) and logistic regression analyses for correlation to each CSF biomarker; Aβ 42 (Aβ42), total tau (T-tau) and phosphorylated tau (P-tau), were performed. Cut-off values were assessed by receiver operating characteristic (ROC) curves. Logistic regression was performed for prediction of clinical AD diagnosis. We assessed the interrater agreement of PET classification as well as for diagnoses, which were made both with and without knowledge of PET results. Thirty-two of the 34 patients (94%) in the Flut+ group and nine of the 30 patients (30%) in the Flut- group had a clinical AD diagnosis. There were significant differences in all CSF biomarkers in the Flut+ and Flut- groups. Aβ42 showed the highest correlation with 18F-Flutemetamol PET with a cut-off value of 706.5 pg/mL, corresponding to sensitivity of 88% and specificity of 87%. 18F-Flutemetamol PET was the best predictor of a clinical AD diagnosis. We found a very high interrater agreement for both PET classification and diagnosis. The present study showed an excellent correlation of Aβ42 in CSF and 18F-Flutemetamol PET and the presented cut-off value for Aβ42 yields high sensitivity and specificity for 18F-Flutemetamol PET. 18F-Flutemetamol PET was the best predictor of clinical AD diagnosis.

1 January 2022 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
EMEbba Gløersen Müller
Ebba Gløersen Müller
CSCaroline Stokke
Caroline Stokke
HSHenning Langen Stokmo
Henning Langen Stokmo
TETrine Holt Edwin
Trine Holt Edwin
AKAnne- Brita Knapskog
Anne- Brita Knapskog
MRMona-Elisabeth Revheim
Mona-Elisabeth Revheim
Evaluation of semi-quantitative measures of 18F-Flutemetamol PET for the clinical diagnosis of Alzheimer’s disease Ebba Gløersen Müller, Caroline Stokke, Henning Langen Stokmo, Trine Holt Edwin, Anne- Brita Knapskog, Mona-Elisabeth Revheim

4 January 2022 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
PDF file
EMEbba Gløersen Müller
Ebba Gløersen Müller
TETrine Holt Edwin
Trine Holt Edwin
BSBjørn Heine Strand
Bjørn Heine Strand
CSCaroline Stokke
Caroline Stokke
MRMona Elisabeth Revheim
Mona Elisabeth Revheim
AKAnne-Brita Knapskog
Anne-Brita Knapskog
Background: Patients with Alzheimer’s disease (AD) show heterogeneity in clinical progression rate, and we have limited tools to predict prognosis. Amyloid burden from 18F-Flutemetamol positron emission tomography (PET), as measured by standardized uptake value ratios (SUVR), might provide prognostic information. Objective: We investigate whether 18F-Flutemetamol PET composite or regional SUVRs are associated with trajectories of clinical progression. Methods: This observational longitudinal study included 94 patients with clinical AD. PET images were semi-quantified with normalization to pons. Group-based trajectory modeling was applied to identify trajectory groups according to change in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) over time. Multinomial logistic regression models assessed the association of SUVRs with trajectory group membership. Results: Three trajectory groups were identified. In the regression models, neither composite nor regional SUVRs were associated with trajectory group membership. Conclusion: There were no associations between CDR progression and 18F-Flutemetamol PET-derived composite SUVRs or regional SUVRs in clinical AD.

11 November 2024 in Neurosurgery
Verified
Journal Article
Open access
EMEbba Gløersen Müller
Ebba Gløersen Müller
DDDaniel Dahlberg
Daniel Dahlberg
BHBjørnar Hassel
Bjørnar Hassel
MRMona-Elisabeth Revheim
Mona-Elisabeth Revheim
JCJames Patrick Connelly
James Patrick Connelly
BACKGROUND AND OBJECTIVES: Bacterial brain abscesses may have long-term clinical consequences, eg, mental fatigue or epilepsy, but long-term structural consequences to the brain remain underexplored. We asked if brain abscesses damage brain activity long term, if the extent of such damage depends on the size of the abscess, and if the abscess capsule, which is often left in place during neurosurgery, remains a site of inflammation, which could explain long-lasting symptoms in patients with brain abscess. METHODS: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG-PET/CT), electroencephalography, and MRI were performed 2 days to 9 years after neurosurgery for bacterial brain abscess. RESULTS: FDG-PET/CT revealed hypometabolism in the neocortex or cerebellum overlying the previous bacterial abscess in 38 of 40 patients. The larger the abscess, the greater was the extent of the subsequent hypometabolism (r = 0.63; p = 3 × 10−5). In 9 patients, the extent of subsequent hypometabolism seemed to coincide with the extent of peri-abscess edema in the acute phase. Follow-up MRI after ≥1 year in 9 patients showed focal tissue loss and gliosis. In 13 patients with abnormal electroencephalography recordings, abnormalities extended beyond the cerebral lobe affected by the abscess, indicating damage to wider brain networks. The abscess capsule had an FDG signal indicating inflammation only during the first week after neurosurgical pus drainage. CONCLUSION: The bigger a brain abscess is allowed to grow, the more extensive is the long-term focal reduction in brain activity. This finding emphasizes the need for rapid neurosurgical intervention. The abscess capsule does not display long-lasting inflammation and probably does not explain long-term symptoms after brain abscess.

21 May 2026 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
VMVere Rose Megens
Vere Rose Megens
PSPeter Wessel Strandhagen
Peter Wessel Strandhagen
EBErik Magnus Berntsen
Erik Magnus Berntsen
EMEbba Gløersen Müller
Ebba Gløersen Müller
KLKoen Van Laere
Koen Van Laere
GLGunn Tove Lium
Gunn Tove Lium
This study pioneers the ability of semi-quantitative A/T/N classification using combined 18F-Flutemetamol (A), 18F-MK-6240 (T) and 18F-FDG (N) positron emission tomography (PET) tracers with binary classifications and standardised scales for Centiloid (A), CenTauR (T), and AD metaROI (N), to clinically describe subjects with Mild Cognitive Impairment (MCI) or Mild Dementia (MD) in Alzheimer's disease (AD). MCI (n = 45, mean age 71.0 ± 8.8, 40% female, MMSE 26.2) and MD (n = 44, mean age 70.1 ± 7.6, 48% female, MMSE 24.1) participants underwent PET with 18F-Flutemetamol for amyloid-β, 18F-MK-6240 tau and/or 18F-FDG for neurodegeneration. Images were semi-quantified using Centiloid, CenTauR, and AD metaROI. Predefined cut-offs classified scans as positive (+) or negative (-), and standard uptake value ratio (SUVR) values semi-quantified A-burden, T-burden, and N-burden. T+ was more frequent in MD (68%) than in MCI (44%). Among T+ , MD participants were more often A+ (39%) than MCI (27%). T-burden differed significantly between MCI and MD (W = 642, p = 0.004). Increasing A-burden, T-burden, and hypometabolism, reflected by lower N-burden were associated with worse performance in Norwegian validated revised mini-mental state-examination (MMSE-NR3) (p = 0.048, < 0.001, and 0.006, respectively), A-burden and N-burden with CERAD Word List Memory Test for immediate and delayed recall (CERAD) (p = 0.041), T-burden with CERAD Word List Memory Test for recognition (CERAD R) (p < 0.001), and N-burden with Clock-drawing test (CDT) (p = 0.023) and Controlled Oral Word Association Test (COWAT) (p = 0.025). The A/T/N classification was most informative for A (+/-) and T (+/-) PET, with T-PET appearing to distinguish MCI from MD, while N-PET correlated most with cognitive impairment.